These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 15767526

  • 1. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW.
    Arch Intern Med; 2005 Mar 14; 165(5):516-20. PubMed ID: 15767526
    [Abstract] [Full Text] [Related]

  • 2. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.
    J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB.
    N Engl J Med; 1999 Jan 14; 340(2):77-84. PubMed ID: 9887158
    [Abstract] [Full Text] [Related]

  • 4. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB, Bartels CC, Verhoog LC, van den Ouweland AM, Niermeijer MF, Brekelmans CT, Klijn JG.
    N Engl J Med; 2001 Jul 19; 345(3):159-64. PubMed ID: 11463009
    [Abstract] [Full Text] [Related]

  • 5. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 6. Quality of life after bilateral prophylactic mastectomy.
    Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM.
    Ann Surg Oncol; 2007 Feb 15; 14(2):686-94. PubMed ID: 17103066
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic bilateral mastectomy: patterns of practice.
    Metcalfe KA, Goel V, Lickley L, Semple J, Narod SA.
    Cancer; 2002 Jul 15; 95(2):236-42. PubMed ID: 12124821
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW.
    J Clin Oncol; 2005 Jul 01; 23(19):4275-86. PubMed ID: 15795415
    [Abstract] [Full Text] [Related]

  • 9. Aesthetic outcome, patient satisfaction, and health-related quality of life in women at high risk undergoing prophylactic mastectomy and immediate breast reconstruction.
    Isern AE, Tengrup I, Loman N, Olsson H, Ringberg A.
    J Plast Reconstr Aesthet Surg; 2008 Oct 01; 61(10):1177-87. PubMed ID: 17938010
    [Abstract] [Full Text] [Related]

  • 10. Predictors of and satisfaction with bilateral prophylactic mastectomy.
    Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F.
    Prev Med; 1995 Jul 01; 24(4):412-9. PubMed ID: 7479633
    [Abstract] [Full Text] [Related]

  • 11. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B, Butow P, Price M, Bennett B, Berry G, Tucker K, National Consortium for Research into Familial Breast Cancer Psychological Group.
    J Womens Health (Larchmt); 2003 Oct 01; 12(8):769-78. PubMed ID: 14588127
    [Abstract] [Full Text] [Related]

  • 12. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    J Clin Oncol; 2008 Mar 01; 26(7):1093-7. PubMed ID: 18195327
    [Abstract] [Full Text] [Related]

  • 13. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC, Lillquist PP, Edge SB.
    Cancer; 2009 Dec 01; 115(23):5404-12. PubMed ID: 19787635
    [Abstract] [Full Text] [Related]

  • 14. Nipple-sparing mastectomy for breast cancer and risk reduction: oncologic or technical problem?
    Sacchini V, Pinotti JA, Barros AC, Luini A, Pluchinotta A, Pinotti M, Boratto MG, Ricci MD, Ruiz CA, Nisida AC, Veronesi P, Petit J, Arnone P, Bassi F, Disa JJ, Garcia-Etienne CA, Borgen PI.
    J Am Coll Surg; 2006 Nov 01; 203(5):704-14. PubMed ID: 17084333
    [Abstract] [Full Text] [Related]

  • 15. Bilateral prophylactic mastectomy in women with an increased risk of breast cancer.
    Tecnologica MAP Suppl; 1999 Jun 01; ():3-6. PubMed ID: 10848037
    [No Abstract] [Full Text] [Related]

  • 16. Bilateral prophylactic mastectomy decision making: A vignette study.
    Stefanek M, Enger C, Benkendorf J, Flamm Honig S, Lerman C.
    Prev Med; 1999 Sep 01; 29(3):216-21. PubMed ID: 10479610
    [Abstract] [Full Text] [Related]

  • 17. A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.
    Fryzek JP, Ye W, Nyrén O, Tarone RE, Lipworth L, McLaughlin JK.
    Breast Cancer Res Treat; 2006 May 01; 97(2):131-4. PubMed ID: 16328720
    [Abstract] [Full Text] [Related]

  • 18. Timing of familial breast cancer in sisters.
    Rebora P, Czene K, Reilly M.
    J Natl Cancer Inst; 2008 May 21; 100(10):721-7. PubMed ID: 18477799
    [Abstract] [Full Text] [Related]

  • 19. Stratification of breast cancer risk in women with atypia: a Mayo cohort study.
    Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJ, Reynolds CA, Hartmann LC.
    J Clin Oncol; 2007 Jul 01; 25(19):2671-7. PubMed ID: 17563394
    [Abstract] [Full Text] [Related]

  • 20. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F.
    Cancer; 2004 Nov 01; 101(9):1977-86. PubMed ID: 15389473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.